Collectively, these data suggest that reduced expression of IGFBP-3 confers resistance to the cell killing effects of IR, whereas upregulation of IGFBP-3 have the reverse effect on ESCC. The gene discussed is IGFBP3; the disease is esophageal squamous cell carcinoma.